Detailed information about the 100 most recent patent applications.
| Application Number | Title | Filing Date | Disposal Date | Disposition | Time (months) | Office Actions | Restrictions | Interview | Appeal |
|---|---|---|---|---|---|---|---|---|---|
| 19021675 | LACTICASEIBACILLUS RHAMNOSUS AFY01 AND APPLICATION OF PRODUCT PREPARED FROM LACTICASEIBACILLUS RHAMNOSUS AFY01 IN INFLAMMATORY COLON CANCER | January 2025 | July 2025 | Allow | 6 | 1 | 0 | No | No |
| 18972671 | PROBIOTICS COMPOSITIONS AND METHOD OF USING THE SAME TO ENHANCE GROWTH AND SOCIAL FUNCTION IN CHILDREN | December 2024 | March 2026 | Allow | 15 | 2 | 1 | No | No |
| 18541328 | COMPOSITION FOR TREATING OF FACIAL DYSMORPHISM IN MUCOPOLYSACCHARIDOSIS | December 2023 | December 2025 | Abandon | 24 | 1 | 0 | No | No |
| 18559060 | EXIGUOBACTERIUM INDICUM AND APPLICATION THEREOF IN SYNTHESIS OF NANO-SELENIUM | November 2023 | December 2024 | Allow | 14 | 1 | 0 | No | No |
| 18485543 | Construction Method and Application of Microorganism Capable of Realizing High Production of Lacto-N-neotetraose | October 2023 | July 2024 | Allow | 9 | 1 | 1 | Yes | No |
| 18447649 | O-METHYLTRANSFERASE PROTEIN WITH HIGHLY SPECIFIC CATALYTIC FUNCTION FOR MULTIPLE BIAS PARENT NUCLEI AND ENCODING GENE AND USE THEREOF | August 2023 | June 2024 | Allow | 10 | 1 | 1 | Yes | No |
| 18267969 | PROBIOTICS COMPOSITIONS AND METHOD OF USING THE SAME TO ENHANCE GROWTH AND SOCIAL FUNCTION IN CHILDREN | June 2023 | March 2026 | Allow | 33 | 2 | 1 | No | No |
| 18191201 | METHOD FOR PREPARING FIBER MATERIAL FROM BANANA PSEUDOSTEM | March 2023 | April 2025 | Abandon | 25 | 3 | 0 | No | No |
| 18098504 | METHOD FOR PREVENTING AND/OR TREATING HELICOBACTER PYLORI-RELATED DISEASE BY USING PARABACTEROIDES GOLDSTEINII AND ITS METABOLITES | January 2023 | September 2025 | Abandon | 32 | 1 | 0 | No | No |
| 18095357 | COMPOSITIONS AND METHODS FOR ACYLATED CONSUMABLES | January 2023 | May 2024 | Abandon | 16 | 1 | 1 | No | No |
| 18148019 | COMPOSITION FOR TREATING OF FACIAL DYSMORPHISM IN MUCOPOLYSACCHARIDOSIS | December 2022 | March 2024 | Abandon | 15 | 1 | 0 | No | No |
| 18145911 | SEPARATION METHOD AND ENRICHMENT CULTURE METHOD OF PSEUDOMONAS, AND REMEDIATION METHOD FOR CONTAMINATED SOIL | December 2022 | November 2025 | Allow | 35 | 2 | 0 | Yes | No |
| 18085674 | POLYMERASES, COMPOSITIONS, AND METHODS OF USE | December 2022 | September 2025 | Abandon | 33 | 0 | 1 | No | No |
| 18002675 | METHODS FOR PREPARING PANTOIC ACID, PANTOTHENIC ACID AND PANTHENOL AS WELL AS SALTS THEREOF | December 2022 | July 2025 | Allow | 31 | 1 | 0 | No | No |
| 18071215 | METHOD FOR ENHANCING SPORTS PERFORMANCE AND ALLEVIATING SARCOPENIA WITH STREPTOCOCCUS THERMOPHILES ST7 FERMENTATION PRODUCT COMPOSITION | November 2022 | January 2025 | Abandon | 25 | 2 | 0 | No | No |
| 18054546 | Method for Isolating and Purifying Bacteriocin Against Drug-Resistant Staphylococcus aureus | November 2022 | March 2024 | Allow | 17 | 2 | 0 | Yes | No |
| 17916368 | COMPOSITIONS AND METHODS FOR INHIBITING VIBRIO INFECTION | September 2022 | November 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17955546 | METHODS FOR PRODUCING EGGSHELL MEMBRANE HYDROLYSATES | September 2022 | July 2024 | Abandon | 21 | 2 | 1 | No | No |
| 17954325 | Composition And Method for Modulating Hydrogen Ion Physiology Related to Weight Loss and Metabolism | September 2022 | April 2024 | Abandon | 19 | 2 | 0 | No | No |
| 17914703 | COMPOSITIONS FOR MODULATING GUT MICROFLORA POPULATIONS, ENHANCING DRUG POTENCY AND TREATING VIRAL INFECTIONS, AND METHODS FOR MAKING AND USING SAME | September 2022 | November 2025 | Abandon | 38 | 1 | 1 | No | No |
| 17951848 | HETEROLOGOUS EXPRESSION OF PHOSPHITE DEHYDROGENASE IN PICOCHLORUM SPP. | September 2022 | September 2024 | Allow | 23 | 2 | 0 | No | No |
| 17930462 | Screening of Engineered Biocatalysts for Oxyfunctionalization of Olefins | September 2022 | February 2025 | Abandon | 29 | 3 | 1 | Yes | No |
| 17904203 | VIABLE BACTERIAL HOST CELL | August 2022 | August 2024 | Abandon | 24 | 1 | 1 | No | No |
| 17791752 | METHODS OF PRODUCING LACTIC ACID FROM UNMODIFIED STARCH | July 2022 | July 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17852841 | INTEGRATED CONVERSION AND OLIGOMERIZATION OF BIO-DERIVED ALCOHOLS | June 2022 | March 2026 | Abandon | 44 | 4 | 1 | Yes | No |
| 17784439 | METHOD FOR CONTINUOUS PROTEIN RECOVERING | June 2022 | August 2025 | Abandon | 38 | 0 | 1 | No | No |
| 17772464 | RECOMBINANT ACE2-FC FUSION MOLECULES AND METHODS OF MAKING AND USING THEREOF | April 2022 | August 2025 | Abandon | 39 | 1 | 1 | No | No |
| 17772222 | FRUCTOSE-6-PHOSPHATE 3-EPIMERASE AND USE THEREOF | April 2022 | December 2025 | Abandon | 44 | 2 | 1 | No | No |
| 17754062 | STRAIN FOR PRODUCING LIPASE AND APPLICATION THEREOF | March 2022 | September 2024 | Allow | 30 | 1 | 0 | No | No |
| 17753739 | ALLULOSE 3-EPIMERASE MUTANT, ENGINEERED BACTERIUM EXPRESSING SAME, AND IMMOBILIZED ENZYME AND IMMOBILIZATION METHOD THEREOF | March 2022 | February 2026 | Allow | 47 | 2 | 1 | Yes | No |
| 17690446 | BIOSYNTHESIS OF CANNABINOIDS AND CANNABINOID PRECURSORS | March 2022 | February 2025 | Abandon | 36 | 0 | 1 | No | No |
| 17640246 | Improved Alpha-Galactosidase Protein for Enzyme Replacement Therapy (ERT) and Methods of Use | March 2022 | October 2025 | Allow | 44 | 2 | 1 | No | No |
| 17618665 | Glycosyltransferase Mutant and Use Therefor | December 2021 | July 2025 | Abandon | 43 | 2 | 1 | No | No |
| 17618091 | Enzymatic Reaction Composition, Method for Increasing Amount of Adenosine Triphosphate (ATP) in Enzymatic Reaction and Application Thereof | December 2021 | November 2024 | Abandon | 35 | 0 | 1 | No | No |
| 17610278 | METHODS AND CELLS FOR MICROBIAL PRODUCTION OF PHYTOCANNABINOIDS AND PHYTOCANNABINOID PRECURSORS | November 2021 | June 2025 | Allow | 43 | 2 | 1 | No | No |
| 17508444 | METHOD FOR MICROSCOPIC EXAMINATION OF PHYTOPLANKTON | October 2021 | November 2024 | Abandon | 37 | 1 | 0 | No | No |
| 17601027 | POLYPEPTIDES HAVING BETA-GLUCANASE ACTIVITY, POLYNUCLEOTIDES ENCODING SAME AND USES THEREOF IN CLEANING AND DETERGENT COMPOSITIONS | October 2021 | July 2025 | Abandon | 46 | 1 | 1 | No | No |
| 17440172 | NOVEL OF L-THREONINE DEHYDRATASE VARIANT AND METHOD OF PRODUCING L-ISOLEUCINE USING THE SAME | September 2021 | August 2025 | Allow | 47 | 2 | 1 | Yes | No |
| 17438810 | MICROBIAL PRODUCTION OF COMPOUNDS | September 2021 | September 2024 | Abandon | 37 | 0 | 1 | No | No |
| 17399423 | Mutant of Nitrile Hydratase Derived from Caldalkalibacillus thermarum | August 2021 | July 2024 | Allow | 36 | 1 | 1 | Yes | No |
| 17429560 | CHEMICALLY MODIFIED LIGNIN AS REDUCING AGENT FOR ENZYMATIC HYDROLYSIS OF LIGNOCELLULOSIC BIOMASS | August 2021 | April 2025 | Abandon | 44 | 2 | 0 | No | No |
| 17423615 | PSEUDOMONAS GRAMINIS STRAIN CAPABLE OF DEGRADING CELLULOSE AT LOW TEMPERATURE AND USE THEREOF | July 2021 | February 2025 | Abandon | 43 | 2 | 0 | No | No |
| 17340466 | Method for Producing Maltodextrin with Single Polymerization Degree by Multienzyme Coupling | June 2021 | November 2024 | Allow | 41 | 2 | 0 | No | No |
| 17323769 | PRODUCTION OF HUMAN MILK OLIGOSACCHARIDES IN MICROBIAL HOSTS WITH ENGINEERED IMPORT / EXPORT | May 2021 | May 2025 | Allow | 48 | 3 | 2 | Yes | No |
| 17288435 | TARGETED CHONDROITINASE ABC FUSION PROTEINS AND COMPLEXES THEREOF | April 2021 | February 2026 | Allow | 58 | 4 | 1 | Yes | No |
| 17284944 | METHOD FOR COLLECTING MICROORGANISM CELL | April 2021 | April 2025 | Abandon | 48 | 2 | 1 | No | No |
| 17278410 | PESTICIDAL COMBINATIONS OF YERSINIA AND BACILLUS | March 2021 | May 2025 | Abandon | 50 | 4 | 1 | No | No |
| 17271615 | NEW PURIFICATION METHOD | February 2021 | May 2024 | Abandon | 39 | 1 | 0 | No | No |
| 17164025 | Methods And Compositions For Producing Fatty Alcohols | February 2021 | July 2024 | Abandon | 41 | 1 | 1 | Yes | No |
| 17261365 | METHODS OF SEPARATING HOST CELL LIPASES FROM A PRODUCTION PROTEIN IN CHROMATOGRAPHIC PROCESSES | January 2021 | March 2025 | Abandon | 50 | 2 | 1 | No | No |
No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.
Examiner EDWARDS, JESSICA FAYE works in Art Unit 1657 and has examined 18 patent applications in our dataset. With an allowance rate of 33.3%, this examiner allows applications at a lower rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 43 months.
Examiner EDWARDS, JESSICA FAYE's allowance rate of 33.3% places them in the 5% percentile among all USPTO examiners. This examiner is less likely to allow applications than most examiners at the USPTO.
On average, applications examined by EDWARDS, JESSICA FAYE receive 1.78 office actions before reaching final disposition. This places the examiner in the 39% percentile for office actions issued. This examiner issues fewer office actions than average, which may indicate efficient prosecution or a more lenient examination style.
The median time to disposition (half-life) for applications examined by EDWARDS, JESSICA FAYE is 43 months. This places the examiner in the 16% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.
Conducting an examiner interview provides a +64.6% benefit to allowance rate for applications examined by EDWARDS, JESSICA FAYE. This interview benefit is in the 98% percentile among all examiners. Recommendation: Interviews are highly effective with this examiner and should be strongly considered as a prosecution strategy. Per MPEP § 713.10, interviews are available at any time before the Notice of Allowance is mailed or jurisdiction transfers to the PTAB.
When applicants file an RCE with this examiner, 25.0% of applications are subsequently allowed. This success rate is in the 38% percentile among all examiners. Strategic Insight: RCEs show below-average effectiveness with this examiner. Carefully evaluate whether an RCE or continuation is the better strategy.
This examiner enters after-final amendments leading to allowance in 100.0% of cases where such amendments are filed. This entry rate is in the 98% percentile among all examiners. Strategic Recommendation: This examiner is highly receptive to after-final amendments compared to other examiners. Per MPEP § 714.12, after-final amendments may be entered "under justifiable circumstances." Consider filing after-final amendments with a clear showing of allowability rather than immediately filing an RCE, as this examiner frequently enters such amendments.
When applicants file petitions regarding this examiner's actions, 100.0% are granted (fully or in part). This grant rate is in the 90% percentile among all examiners. Strategic Note: Petitions are frequently granted regarding this examiner's actions compared to other examiners. Per MPEP § 1002.02(c), various examiner actions are petitionable to the Technology Center Director, including prematureness of final rejection, refusal to enter amendments, and requirement for information. If you believe an examiner action is improper, consider filing a petition.
Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 2% percentile). This examiner rarely makes examiner's amendments compared to other examiners. You should expect to make all necessary claim amendments yourself through formal amendment practice.
Quayle Actions: This examiner issues Ex Parte Quayle actions in 0.0% of allowed cases (in the 2% percentile). This examiner rarely issues Quayle actions compared to other examiners. Allowances typically come directly without a separate action for formal matters.
Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:
Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.
No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.
Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.
Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.